5 Questions with Stephen Choi and David Marcus: Securities Enforcement Empirical Database
Stephen Choi, NYU Professor of Law and Director of the NYU Pollack Center for Law & Business; and David Marcus, Senior Vice President, Cornerstone Research.
European Commission Enquiry of Credit Default Swaps Market
The Commission dropped its investigation into allegations that 13 large investment banks had prevented exchanges from entering the European CDS market.
Assessment of Actuarial Services for a University’s Health Insurance Plan
Cornerstone Research worked with two actuaries in this case to assess the actuarial services provided to the university system for its student health plan.
Allergan Takeover Bid
Cornerstone Research worked with two experts who testified on Rule 14e-3 allegations that a hedge fund violated federal securities law on disclosures in cash tender offers.
In re BP p.l.c. Securities Litigation—June 2016 Ruling
U.S. District Court Judge Keith P. Ellison ruled on pending motions for summary judgment, granting numerous elements of the defendants’ motion and denying the plaintiffs’ motion in its entirety.
Valuation of Illiquid Municipal Bonds
For an internal investigation, Cornerstone Research assessed bond holding valuations and calculated the impact on mutual fund shareholders.
Certain Passenger Vehicle Tires and Light Truck Tires from China
Cornerstone Research experts evaluated whether a reduction in tire imports from China would have an impact on the production of U.S. domestically produced tires.
Analysis of Consulting Services to Self-Insured Student Health Plan
Cornerstone Research worked with four experts in this case involving actuarial consulting on a university system’s student health plan.
Considerations for Blow Provisions in Securities Class Action Settlements
Without careful structuring, a blow provision may fail in its intended purpose of allowing defendants to terminate or renegotiate a class settlement when opt-out exposure reaches an unacceptable level.
Alleged Theft of Trade Secrets for a Drug in Development
Professor Sean Nicholson and Cornerstone Research analyzed the loss in value of a drug in development due to the advantage that the manufacturer of a competing drug in development obtained…
How can we help you?
If you are looking for a publication not on our website, contact us.